Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
American Journal of Respiratory Cell and Molecular Biology|June 9, 2022
Kasugamycin Is a Novel Chitinase 1 Inhibitor with Strong Antifibrotic Effects on Pulmonary FibrosisJae-Hyun Lee, Chang-Min Lee, Joyce H Lee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 2018
Galectin-3 Interacts with the CHI3L1 Axis and Contributes to Hermansky-Pudlak Syndrome Lung DiseaseYang Zhou, Chuan Hua He, Daniel S Yang, et al.
Cancer Research|April 27, 2023
Chi3l1 Is a Modulator of Glioma Stem Cell States and a Therapeutic Target in GlioblastomaCharlotte Guetta-Terrier, David Karambizi, Bedia Akosman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 18, 2024
Chitinase 3-like-1 Inhibits Innate Antitumor and Tissue Remodeling Immune Responses by Regulating CD47-SIRPα- and CD24-Siglec10-Mediated PhagocytosisBing Ma, Suchitra Kamle, Takayuki Sadanaga, et al.
Immunity|December 1, 2023
The tumor-derived cytokine Chi3l1 induces neutrophil extracellular traps that promote T cell exclusion in triple-negative breast cancerTarek Taifour, Sherif Samer Attalla, Dongmei Zuo, et al.
Biorxiv : the Preprint Server for Biology|January 14, 2021
Chitinase 3-like-1 is a Therapeutic Target That Mediates the Effects of Aging in COVID-19Suchitra Kamle, Bing Ma, Chuan Hua He, et al.
JCI Insight|November 8, 2021
Chitinase 3-like-1 is a therapeutic target that mediates the effects of aging in COVID-19Suchitra Kamle, Bing Ma, Chuan Hua He, et al.
Cells|February 26, 2026
CHI3L1 Expression in Chordoma: Implications for Immunotherapeutic InterventionBeatrice Campilan, Christian Godinez, Jonathan Arditi, et al.
JCI Insight|February 3, 2026
The CHI3L1-neutrophil axis drives immune suppression and breast cancer metastatic disseminationTarek Taifour, Adéline Massé, Yu Gu, et al.
Biorxiv : the Preprint Server for Biology|August 15, 2020
Natural Killer cell activation, reduced ACE2, TMPRSS2, cytokines G-CSF, M-CSF and SARS-CoV-2-S pseudovirus infectivity by MEK inhibitor treatment of human cellsLanlan Zhou, Kelsey Huntington, Shengliang Zhang, et al.
Pageof 4